Cargando…

Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study

BACKGROUND: Hyponatremia is an independent predictor of poor prognosis, including increased mortality and readmission, in COPD patients. Identifying modifiable etiologies of hyponatremia may help reduce adverse events in patients with AECOPD. Therefore, the aim of this study was to explore the risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Min, Wang, Xiaoyu, Wang, Hanchao, Du, Fawang, Yao, Yu, Wang, Xiaochuan, Wang, Jiajia, Yang, Juan, Xiong, Wei, Wang, Qin, Ren, Xubin, Zhu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884134/ https://www.ncbi.nlm.nih.gov/pubmed/36709254 http://dx.doi.org/10.1186/s12890-023-02328-4

Ejemplares similares

Machine learning reveals sex differences in clinical features of acute exacerbation of chronic obstructive pulmonary disease: A multicenter cross-sectional study
por: Chen, Zhihong, et al.
Publicado: (2023)

Remote Monitoring for Prediction and Management of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)
por: Pépin, Jean-Louis, et al.
Publicado: (2022)

Effect of Glycemic Control on Outcome of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD)
por: Guha, Abhraneel Parames
Publicado: (2021)

Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
por: Wang, Ying, et al.
Publicado: (2014)

The Role of the Clinical Pharmacist on the Health Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
por: Gong, Yanqing, et al.
Publicado: (2022)

Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study
por: Xiao, Wei, et al.
Publicado: (2019)

Effects of air pollution on acute exacerbation of chronic obstructive pulmonary disease: a descriptive retrospective study (pol-AECOPD)
por: Morantes-Caballero, Jairo A, et al.
Publicado: (2019)

Better response to Tanreqing injection in frequent acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients—Real-world evidence from a nationwide registry (ACURE) study
por: Fan, Guohui, et al.
Publicado: (2023)

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
por: Mathioudakis, Alexander G., et al.
Publicado: (2020)

Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial
por: Haifeng, Wang, et al.
Publicado: (2012)

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
por: Ma, Yiming, et al.
Publicado: (2021)

An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD
por: Xiong, Wei, et al.
Publicado: (2020)

The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD)
por: Lv, Mei-Yu, et al.
Publicado: (2021)

Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?
por: Kherad, Omar, et al.
Publicado: (2014)

Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study
por: Wang, Hong, et al.
Publicado: (2022)

Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD
por: Moretti, Maurizio, et al.
Publicado: (2015)

Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
por: Brennan, Michelle, et al.
Publicado: (2022)

Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial
por: Huang, Lixue, et al.
Publicado: (2021)

Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study
por: Dai, Guangming, et al.
Publicado: (2020)

The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection
por: Song, Yuanlin, et al.
Publicado: (2016)

Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015)

Correlations of Silent Information Regulator of Transcription 1 (SIRT1) Expression, Inflammatory Factors, and Oxidative Stress with Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
por: Zhao, Xin, et al.
Publicado: (2021)

The features of AECOPD with carbon dioxide retention
por: Wei, Xia, et al.
Publicado: (2018)

Atypical Pathogen Distribution in Chinese Hospitalized AECOPD Patients: A Multicenter Cross-Sectional Study
por: Feng, Chenye, et al.
Publicado: (2021)

Acupuncture as adjunctive therapy for patients with AECOPD: study protocol for a multicenter, randomized controlled trial
por: Yang, Chunyan, et al.
Publicado: (2023)

Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis
por: Hoult, George, et al.
Publicado: (2022)

Impact of Hyponatremia on COPD Exacerbation Prognosis
por: García-Sanz, María-Teresa, et al.
Publicado: (2020)

Risk of temperature, humidity and concentrations of air pollutants on the hospitalization of AECOPD
por: Chen, Cai, et al.
Publicado: (2019)

Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure
por: Yao, Can, et al.
Publicado: (2021)

Dynamics of inflammation resolution and symptom recovery during AECOPD treatment
por: Chang, Chun, et al.
Publicado: (2014)

Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?
por: Zeng, Yuqin, et al.
Publicado: (2021)

The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort
por: Wang, Juan, et al.
Publicado: (2020)

Clinical Features and Outcomes of Acute Exacerbation in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Heart Disease: A Multicenter Observational Study
por: You, Lingyan, et al.
Publicado: (2021)

Superior Predictive Value of D-Dimer to the Padua Prediction Score for Venous Thromboembolism in Inpatients with AECOPD: A Multicenter Cohort Study
por: Zhou, Chen, et al.
Publicado: (2022)

The role of CAT in evaluating the response to treatment of patients with AECOPD
por: Zhou, Aiyuan, et al.
Publicado: (2018)

Efficiency and Safety of Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: He, Mei, et al.
Publicado: (2015)

Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study
por: Winther, Jacob A., et al.
Publicado: (2016)

Investigation on the Relationship between Sleep Quality and Depression and Anxiety in Hospitalized Patients with Different Levels of AECOPD
por: Liu, Dingfang, et al.
Publicado: (2022)

Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study
por: Burst, Volker, et al.
Publicado: (2017)

BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease
por: Duan, Yifei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gnmnhl55ct840t8ao58gq970du